Amgen (NASDAQ: AMGN) today announced that a Delaware jury delivered a verdict in Amgen's favor upholding the validity of two ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE